Harbin Gloria Pharmaceuticals Co (SZSE:002437) 3-Year Revenue Growth Rate : -4.90% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Harbin Gloria Pharmaceuticals Co 3-Year Revenue Growth Rate?

Harbin Gloria Pharmaceuticals Co's Revenue per Share for the three months ended in Mar. 2024 was ¥0.27.

During the past 12 months, Harbin Gloria Pharmaceuticals Co's average Revenue per Share Growth Rate was -14.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -4.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -13.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Harbin Gloria Pharmaceuticals Co was 53.30% per year. The lowest was -16.90% per year. And the median was 14.90% per year.

Competitive Comparison of Harbin Gloria Pharmaceuticals Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Gloria Pharmaceuticals Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harbin Gloria Pharmaceuticals Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Gloria Pharmaceuticals Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Harbin Gloria Pharmaceuticals Co's 3-Year Revenue Growth Rate falls into.

Harbin Gloria Pharmaceuticals Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Harbin Gloria Pharmaceuticals Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Harbin Gloria Pharmaceuticals Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

N/A

Address

Beijing Road No 29, Harbin Economic and Technological Development Zone, Harbin, CHN, 150025

Website

http://www.gloria.cc

Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.

Executives

Guo Yun Pei	Independent director
Wang Yu	Supervisors
Yang Hong Bing	Director
Diao Xiu Qiang	Directors, executives
Liu Yue Yin	Securities Affairs Representative
Guo Lei Feng	Directors, Directors, and Executives
Li Jun Ling	Director
Yang Hai Feng	Executives
Zhang Su Mei	Supervisors
Zhu Ji Man	Director

Harbin Gloria Pharmaceuticals Co (SZSE:002437) Headlines

No Headlines